Evolent Health (EVH) Free Cash Flow (2015 - 2026)

Evolent Health's Free Cash Flow history runs 12 years deep, the most recent figure standing at -$7.4 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 83.37% year-over-year to -$7.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 114.35% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 177.59% from the prior year.
• Free Cash Flow retreated to -$7.4 million in Q1 2026 per EVH's latest filing, from $41.0 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $83.3 million in Q4 2023 and bottomed at -$66.0 million in Q1 2022.
• The 5-year median for Free Cash Flow is -$438000.0 (2024), against an average of $3.2 million.
• Across the five-year window, Free Cash Flow soared 502.64% in 2023 and sank 820.09% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at $25.0 million in 2022, then jumped by 233.96% to $83.3 million in 2023, then sank by 138.86% to -$32.4 million in 2024, then jumped by 226.73% to $41.0 million in 2025, then slumped by 118.01% to -$7.4 million in 2026.
• Per Business Quant, the three latest EVH Free Cash Flow figures stand at -$7.4 million (Q1 2026), $41.0 million (Q4 2025), and $6.8 million (Q3 2025).